APA (7th ed.) Citation

Zheng, Y., Song, D., Guo, M., Wang, C., Ma, M., Tao, G., . . . An, Y. (2025). EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in Colorectal cancer. Journal of Experimental & Clinical Cancer Research, 44(1), 1-22. https://doi.org/10.1186/s13046-025-03277-y

Chicago Style (17th ed.) Citation

Zheng, Yongbin, et al. "EGFR Inhibition Augments the Therapeutic Efficacy of the NAT10 Inhibitor Remodelin in Colorectal Cancer." Journal of Experimental & Clinical Cancer Research 44, no. 1 (2025): 1-22. https://doi.org/10.1186/s13046-025-03277-y.

MLA (8th ed.) Citation

Zheng, Yongbin, et al. "EGFR Inhibition Augments the Therapeutic Efficacy of the NAT10 Inhibitor Remodelin in Colorectal Cancer." Journal of Experimental & Clinical Cancer Research, vol. 44, no. 1, 2025, pp. 1-22, https://doi.org/10.1186/s13046-025-03277-y.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.